GEN Exclusives

More »

GEN Poll

More »
Sep 30, 2013

Firms Ripe for Takeover

Wall Street analysts have labeled seven biotech firms as potential takeover targets this year, as mentioned in GEN’s recent list, “Takeover Targets: Who Is First on the List?”. Of the seven, which do you think is the MOST likely target?

Which company below do you think is the MOST likely to be acquired by a larger biotech partner or pharma giant?

Ariad Pharmaceuticals
 
  15.4%
Biomarin Pharmaceutical
 
  16.9%
Clovis Oncology
 
  6.7%
Incyte
 
  14.9%
Medivation
 
  4.1%
Regeneron Pharmaceuticals
 
  17.4%
Seattle Genetics
 
  24.6%

More Polls » View Results »

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Mindclones and Immortality

Is the idea of making a software copy of a human mind something in the realm of reality or science fiction?